Results 131 to 140 of about 42,835 (204)

Screening of kinase inhibitors in the triple negative KRAS G13D-mutated MDA-MB-231 breast cancer cell line. [PDF]

Sci Rep
Stickler S, Eggerstorfer MT, Rieche M, Arslan S, Teufelsbauer M, Hohenegger M, Weigl L, Hamilton G.   +7 more
europepmc   +1 more source

Adverse Respiratory Reactions to Tyrosine Kinase Inhibitors: A Disproportionality Analysis of Spontaneous Reports from European Countries. [PDF]

Life (Basel)
Ammendolia I, Mannucci C, Esposito E, Calapai G, Currò M, Midiri P, Mondello C, Cancellieri A, Cardia L, Calapai F.   +9 more
europepmc   +1 more source

Real-World Outcomes With Low-Dose Dasatinib (50 mg) in Imatinib-Resistant Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Analysis of Efficacy and Safety. [PDF]

Cancer Rep (Hoboken)
Gangadaran N, Mamlekar H, Saha S, Kashyap R, Yadav S, Rahman K, Gupta R, Vijayaran M, Singh M, Chandra D.   +9 more
europepmc   +1 more source

Safety profiles of dasatinib in pediatric patients: a real-world pharmacovigilance assessment based on the FAERS database. [PDF]

Jpn J Clin Oncol
Yang Y, Ma W, Fu H, Zhou Y, Lin Y.
europepmc   +1 more source

A phase 3 study of intensive chemotherapy with or without dasatinib in core-binding factor acute myeloid leukemia.

Blood
Döhner H, Späth D, Saadati M, Fiedler W, Götze K, Koller E, Westermann J, Vogel W, Heuser M, Lübbert M, Tischler HJ, Germing U, Teichmann LL, Fransecky L, Wölfler A, Nachbaur D, Hertenstein B, Schroers R, Martens U, von Harsdorf S, Radsak M, Aschauer G, Weißhaar S, Corbacioglu A, Schrade A, Gaidzik VI, Thol F, Paschka P, Bullinger L, Benner A, Döhner K, Ganser A.   +31 more
europepmc   +1 more source

Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatment. [PDF]

iScience
Rebecca VW, Xiao M, Kossenkov A, Godok T, Brown GS, Fingerman D, Alicea GM, Wei M, Ji H, Portuallo M, Bravo J, Elad V, Chen Y, Toska E, Fane ME, Couts KL, Villanueva J, Nathanson K, Arun KM, Warrier G, Yin X, Ding J, Liu Q, Goyal Y, Gopal YNV, Davies MA, Herlyn M.   +26 more
europepmc   +1 more source

Cellular senescence and metabolic aging in type 2 diabetes: mechanistic insights and translational implications. [PDF]

Front Endocrinol (Lausanne)
Syed AR, Aloti RA, Awad BJ, Alghoul WII, Hassan MAMSA, Kharoufeh A, Rangraze I.   +6 more
europepmc   +1 more source

Dasatinib and Quercetin Alleviate Retinal Ganglion Cell Dendritic Shrinkage and Promote Axonal Regeneration in Mice with Optic Nerve Injury. [PDF]

Int J Mol Sci
Bin X, Zhou S, Xu Y, Chen S, Chen S, Yao W, Cao Y, Qiu K, Ng TK.   +8 more
europepmc   +1 more source

Toward the future management of patients with CML and Ph + ALL: real-world safety insights from dasatinib pharmacovigilance. [PDF]

Front Med (Lausanne)
Lu Z, Shang G, Zeng Y, Lu X.
europepmc   +1 more source

PTEN Loss Promotes PI3Kβ Phosphorylation and EPHA2/SRC/p-PI3KβY962 Complex Assembly to Drive Tumorigenesis. [PDF]

Cancer Discov
Tang S, Zhou Q, Bergholz JS, Jiang T, Wang W, Ji R, Huang W, Wu J, Li Y, Wan X, He X, Jing Q, Sun M, Johnson JL, Yaron-Barir TM, Li DQ, Dai B, Wang Z, Li X, Cantley LC, Roberts TM, Zhao JJ.   +21 more
europepmc   +1 more source